Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

15 Sept 2022

Abstract excerpt

BACKGROUND: Renal cell carcinoma (RCC) is a heterogeneous disease comprising histologically defined subtypes. For therapy selection, precise subtype identification and individualized prognosis are mandatory, but currently limited. Our aim was to refine subtyping and outcome prediction across main subtypes, assuming that a tumor is composed of molecular features present in distinct pathological subtypes. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36109798
DOI: 10.1186/s13073-022-01105-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyPMID 36109798Read ↗

Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomicsSemantic proximity Read ↗

Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.Semantic proximity Read ↗

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Semantic proximity Read ↗

Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic BoundariesSemantic proximity Read ↗

Multi-omics comprehensive analysis of renal clear cell carcinoma to distinguish subtypes with different molecular characterizations and therapeutic strategiesSemantic proximity Read ↗

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell CarcinomaSemantic proximity Read ↗

Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis.Semantic proximity Read ↗

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profilesSemantic proximity Read ↗

Comprehensive proteogenomic characterization of rare kidney tumorsSemantic proximity Read ↗

Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.Semantic proximity Read ↗

Development of a Prognostic Index for Clear Cell Renal Cell Carcinoma Using Machine Learning and Multi-omics Analysis to Enhance Clinical Outcomes and Drug SensitivitySemantic proximity Read ↗

Clinical value and in vitro validation of gene and molecular subtype identification in renal clear cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.